Users of Ozempic and other drugs are shunning items like energy drinks and salty snacks, research shows. But there are ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Adverse events were frequent, and most were gastrointestinal-related, including nausea, vomiting, diarrhea, constipation ...

Patients with overweight or obesity who used maridebart cafraglutide experienced significant weight loss at 1 year, according ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

A new weight ... their weight loss journey. "Our service helps patients achieve their goals safely, with the reassurance of personalised care from experienced professionals." GLP-1 agonists, ...

Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

DENVER--(BUSINESS WIRE)--Virta Health, the leader in diabetes reversal and sustainable ... results showing sustained weight loss following complete GLP-1 deprescription and 13% average weight ...

A new weight loss service offering GLP-1 ... care from experienced professionals." GLP-1 agonists, traditionally used for managing Type 2 diabetes, have gained popularity as a treatment for ...